Antiviral medications such as remdesivir, and anti-inflammatory regimens such as corticosteroids, interleukin-6 (IL-6) inhibitors, and Janus kinase inhibitors have also been reported to improve clinical outcomes in hospitalized COVID-19 patients in specific subgroups (6–9). The gene discussed is IL6; the disease is COVID-19.